{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:31:01Z","timestamp":1771039861192,"version":"3.50.1"},"reference-count":16,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":385,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH100216"],"award-info":[{"award-number":["R01MH100216"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1002\/pds.3697","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T05:04:50Z","timestamp":1407819890000},"page":"1026-1028","source":"Crossref","is-referenced-by-count":5,"title":["Evidence accumulates on the association between topiramate use early in pregnancy and the risk of oral clefts"],"prefix":"10.1002","volume":"23","author":[{"given":"Sonia","family":"Hernandez-Diaz","sequence":"first","affiliation":[{"name":"Department of Epidemiology; Harvard School of Public Health; Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,8,12]]},"reference":[{"issue":"5","key":"10.1002\/pds.3697-BIB0001|pds3697-cit-0001","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1528-1167.2009.02130.x","article-title":"Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: report of the quality standards subcommittee and therapeutics and technology assessment subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"issue":"1-2","key":"10.1002\/pds.3697-BIB0002|pds3697-cit-0002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eplepsyres.2011.02.012","article-title":"Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population","volume":"95","author":"Landmark","year":"2011","journal-title":"Epilepsy Res"},{"issue":"21","key":"10.1002\/pds.3697-BIB0003|pds3697-cit-0003","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"key":"10.1002\/pds.3697-BIB0004|pds3697-cit-0004","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations","volume":"362","author":"Jentink","year":"2010","journal-title":"New England J Med"},{"issue":"Suppl 5","key":"10.1002\/pds.3697-BIB0005|pds3697-cit-0005","first-page":"32","article-title":"Mechanisms of teratogenesis: folic acid and antiepileptic therapy","volume":"42","author":"Dansky","year":"1992","journal-title":"Neurology"},{"key":"10.1002\/pds.3697-BIB0006|pds3697-cit-0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c6581","article-title":"Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study","volume":"341","author":"Jentink","year":"2010","journal-title":"Br Med J"},{"key":"10.1002\/pds.3697-BIB0007|pds3697-cit-0007","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000318293.28278.33","article-title":"Topiramate in pregnancy. Preliminary experience from the UK epilepsy and pregnancy register","volume":"71","author":"Hunt","year":"2008","journal-title":"Neurology"},{"issue":"19","key":"10.1002\/pds.3697-BIB0008|pds3697-cit-0008","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2011.624","article-title":"Newer-generation antiepileptic drugs and the risk of major birth defects","volume":"305","author":"Molgaard-Nielsen","year":"2011","journal-title":"JAMA: J Am Med Assoc"},{"issue":"5","key":"10.1002\/pds.3697-BIB0009|pds3697-cit-0009","doi-asserted-by":"crossref","first-page":"405 e401","DOI":"10.1016\/j.ajog.2012.07.008","article-title":"Use of topiramate in pregnancy and risk of oral clefts","volume":"207","author":"Margulis","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/pds.3697-BIB0010|pds3697-cit-0010","doi-asserted-by":"crossref","DOI":"10.1002\/pds.3612","article-title":"Topiramate use in pregnancy and the birth prevalence of oral clefts","author":"Mines","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/pds.3697-BIB0011|pds3697-cit-0011","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0140-6736(76)91403-3","article-title":"Anticonvulsants and parental epilepsy in the development of birth defects","volume":"1","author":"Shapiro","year":"1976","journal-title":"Lancet"},{"key":"10.1002\/pds.3697-BIB0012|pds3697-cit-0012","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-642-60447-8_3","volume-title":"Drug Toxicity in Embryonic Development II","author":"Finnell","year":"1997"},{"issue":"4","key":"10.1002\/pds.3697-BIB0013|pds3697-cit-0013","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0890-6238(91)90091-S","article-title":"Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: human studies","volume":"5","author":"Dansky","year":"1991","journal-title":"Reprod Toxicol"},{"key":"10.1002\/pds.3697-BIB0014|pds3697-cit-0014","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogenicity of anticonvulsant drugs","volume":"344","author":"Holmes","year":"2001","journal-title":"New England J Med"},{"issue":"11","key":"10.1002\/pds.3697-BIB0015|pds3697-cit-0015","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.annepidem.2011.08.002","article-title":"Use of antiepileptic medications in pregnancy in relation to risks of birth defects","volume":"21","author":"Werler","year":"2011","journal-title":"Ann Epidemiol"},{"key":"10.1002\/pds.3697-BIB0016|pds3697-cit-0016","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/j.1528-1167.2008.01696.x","article-title":"Valproate teratogenicity and epilepsy syndrome","volume":"49","author":"Bromfield","year":"2008","journal-title":"Epilepsia"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3697","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pds.3697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:26:33Z","timestamp":1625354793000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3697"}},"subtitle":["TOPIRAMATE AND ORAL CLEFTS"],"short-title":[],"issued":{"date-parts":[[2014,8,12]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3697","relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8,12]]}}}